Pharma
Amgen exec on where the company’s experimental obesity treatment stands
The biotech’s head of obesity gave us a closer look.
Therapeutic Areas & Drug Cases
In-depth reporting on therapeutic areas & drug cases, from market shifts and clinical breakthroughs to the essential updates shaping the sector.
Pharma
Johnson & Johnson reports mixed Q3 earnings
The company’s pharmaceutical segment performed well, while medtech suffered.
Pharma
Novo Nordisk announces rebrand amid competition with Eli Lilly
The two pharma giants are in competition for dominance in the obesity and diabetes markets.
Pharma
Pharma companies home in on GLP-2s and GLP-3s in race to innovate on obesity treatments
Companies are looking at combining several hormone-like molecules to boost results.
Pharma
Some telehealth GLP-1 prescriptions have little clinician oversight, little regulation
A recent study from JAMA highlights what some worry are gaps in regulation.
Pharma
3 treatments from 2026 that could alter the future of medicine
We’re diving into new medicines and why they matter.
Pharma
Samsung, Massachusetts General Hospital team up to study GLP-1 muscle loss
Galaxy Watch wearers will get alerts about health and exercise to see if they can maintain their strength.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
